Why is Nath Bio-Genes falling/rising?

As of 24-Jul, Nath Bio-Genes (India) Ltd is experiencing a decline in its stock price, currently at 190.00, reflecting a decrease of 1.0 or 0.52%. The stock has underperformed its sector by 0.44% today, and its delivery volume has significantly dropped by 82.8% compared to the 5-day average, indicating falling investor participation. Over the past week, the stock has decreased by 1.86%, and it has shown a substantial decline of 20.93% over the last year, while its profits have only risen by 1.6%. Despite having a low Price to Book Value of 0.6 and trading at a discount compared to peers, the company’s weak long-term fundamental strength, highlighted by a -0.69% CAGR growth in operating profits over the last five years, contributes to the negative sentiment surrounding the stock.
In the broader market context, the stock's performance has been notably weaker than the benchmark, with a 1-month return of -6.79% compared to a slight gain of 0.16% for the Sensex. The stock has consistently underperformed against the benchmark over the last three years, which further diminishes investor confidence. The majority of shareholders being non-institutional may also indicate a lack of institutional support, which can affect liquidity and market perception. Overall, the combination of declining investor participation, poor historical performance relative to the benchmark, and weak long-term fundamentals are contributing to the stock's downward movement.